Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
1.520
+0.100 (7.04%)
At close: Jun 26, 2026, 4:00 PM EDT
1.480
-0.040 (-2.63%)
After-hours: Jun 26, 2026, 7:55 PM EDT
Acurx Pharmaceuticals Employees
Acurx Pharmaceuticals had 4 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
4
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,874,582
Market Cap
6.53M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| BioAtla | 41 |
| NextCure | 40 |
| Cardio Diagnostics Holdings | 17 |
| Soligenix | 14 |
| Purple Biotech | 10 |
| XTL Biopharmaceuticals | 10 |
| CNS Pharmaceuticals | 8 |
| Silo Pharma | 3 |
ACXP News
- 11 days ago - Acurx Pharmaceuticals Announces Presentation of Results from Leiden University Medical Center Public-Private Partnership for Its DNA pol IIIC Inhibitors at the Leiden Early Drug Discovery & Development (LED3) Scientific Conference - PRNewsWire
- 6 weeks ago - Acurx Pharmaceuticals Earnings Call Transcript: Q1 2026 - Transcripts
- 6 weeks ago - Acurx Pharmaceuticals Quarterly report: Q1 2026 - Filings
- 6 weeks ago - Acurx Pharmaceuticals Earnings release: Q1 2026 - Filings
- 6 weeks ago - Acurx Pharmaceuticals, Inc. Reports First Quarter 2026 results and Provides Business Update - PRNewsWire
- 7 weeks ago - Acurx files to sell 1.65M shares of common stock for holders - TheFly
- 7 weeks ago - Acurx files to sell 1.3M shares of common stock for holders - TheFly
- 7 weeks ago - Acurx Announces Scientific Poster Presentation of its DNA pol IIIC Inhibitors' Microbiome Evaluation at ESCMID Global 2026 - PRNewsWire